黄连膏治疗低位肛周脓肿术后创面愈合的临床应用研究

《黄连膏治疗低位肛周脓肿术后创面愈合的临床应用研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、学校代号10199学号20124119089硕士学位论文黄连膏治疗低位肛周脓肿术后创面愈合的临床应用研究ClinicalstudyonthewoundhealingofHuanglianointmentinthetreatmentoflowperianalabscessafteroperation学位申请人都先爽导师姓名职称周建华教授专业名称中医外科学研究方向中医药治疗肛肠疾病的研究培养方式全日制申请学位类型专业学位论文提交日期2015年4月分类号密级ＵＤＣ编号硕±学位论文黄连帝治疗低位肛周脈肿术后创面愈合的临床应用研究Ｃ

2、ｌｉｎｉｃａｌｓｔｕｄｙｏｎｔｈｅｗｏｕｎｄｈｅａｌｉｎｏｆｇＨｕａｎＵａ打ｏｉｎｔｍｅｎｔｉｎｔｈｅｔｒｅａｔｍｅｎｔｏｆｌｏｗｇｐｅｒｉａｎａｌａｂｓｃｅｓｓａｆｔｅｒｏｐｅｒａｔｉｏｎ都先爽指导教师姓名；周建华教授长春中医药大学附属医院申请学位级别：硕±专业名称：中医外科学研究方向：中医药治砖肛肠疾病的研究论文提交日期：２０１５年４月论文答辩日期：２０１５年６月学位授予单位；长春中医药大学、ｆ提交碗认：作者签导师签名：＿（］《个长春中医药大学学位论女原创性声明．独立进行研

3、究工作所取得的成果。本人郑重声明：所呈父的学位论文，是个人在导师的指导下除文中已经特别加注明引用的内容外，本论文不含任何其化个人或集体已经发表或撰写过的作品成果。对本文的研究做出重耍贡献的个人和集体，巧已在文中Ｕ明确方式标明并致谢。本人完全意识到本声明的法律结果由本人承巧。学位论文作者签－ＳＡ年（月义ＢＪ关于学位论文知识产救巧屬的声明本人郑重声明：所呈交的学位论文，是本人在导师指导下自选课题或导师承担的国家立项资助权的计为划长课题的一部分，系本人在导师指导和资助Ｔ独立进行租院工作所取得的成果，知识产权归屬春中医药大学和本

4、人导师巧有。持化论声文明，本声巧的－－－切法律责任由本人承担Ｃ作者签导教方师签名年（月Ｊｉ曰关于ｊ学位论文使用援权的声明有关机论文本人完全了解长春中医药大学有关保留使用学位论文的规定．同意学校保留并向构送交部的复印件和电子版，允许被豈阅和借阐。本人授权长．替中医药大学可Ｗ将本学位论文的全部或分内容编入有关数据库进行检索，可１＾＾采用影印、缩印或其他复印手段保存和汇编本学位论文。（保密论文在解密后应遵守此规定）括（月兴１刮１长春中医药大学2015届硕士学位论文目录目录中文摘要··························

5、·····································································1英文摘要·······························································································2英文缩略语····························································································3前言·············

6、··················································································4文献综述·······························································································51中医学和现代医学对肛周脓肿的认识························································52中医学治疗肛周脓肿术后创面愈合的临床应用研究···

7、···································53现代医学治疗肛周脓肿术后创面愈合的临床应用研究···································84黄连膏的临床应用研究··········································································10临床研究·······························································································1

8、71临床资料·············